Page Section: Breadcrumbs
you are here:
Home
> Decisions & Case Notes > Case Notes > Misdiagnosis of ectopic pregnancy and administration of methotrexate when pregnancy subsequently found to be intrauterine (02HDC10862)
Page Section: Left Content Column
Page Section: Centre Content Column
Misdiagnosis of ectopic pregnancy and administration of methotrexate when pregnancy subsequently found to be intrauterine (02HDC10862)
Download Misdiagnosis of ectopic pregnancy and administration of methotrexate when pregnancy subsequently found to be intrauterine (02HDC10862) (PDF 15Kb)
(02HDC10862, 23 June 2004)
Obstetrician ~ Fertility centre
~ Ectopic pregnancy ~ Standard of care ~ Information about
condition ~ Rights 4(1), 6(1)(a), 6(1)(b)
A woman underwent in-vitro fertilisation after she and her husband
had experienced difficulties trying to conceive their first child
for two and a half years; two fertilised eggs were placed in the
woman's uterus. The fertility clinic staff carried out a series of
hormone assays via blood tests to assess the viability of the
pregnancy over the following three weeks, plotting the results on a
logarithmic graph. Initially the hormone levels rose more slowly
than normal and the woman was informed that the pregnancy was
unlikely to be viable. A further test showed a noticeable rise in
the hormone level, and the woman was suffering some pelvic
discomfort; four days later, the hormone level had again risen
considerably.
A transvaginal ultrasound scan, performed at the fertility clinic
by the obstetrician, noted that the uterus was empty. Because of
this, and the abnormal slow early rise in the hormone levels and
evidence of a speck of vaginal bleeding, the obstetrician diagnosed
a probable ectopic pregnancy (a pregnancy outside the uterus). She
discussed management options with the couple: continued hormonal
monitoring while waiting for the ectopic pregnancy tissue to die
and be reabsorbed (expectant management), treatment with
methotrexate, which destroys fast-growing cells, and surgical
treatment with laparoscopy; the possibility of a normal
intrauterine pregnancy was not discussed. Included in the
discussion was the risk of the fallopian tube rupturing if the
expectant management option were taken, and the side effects and
possible failure of methotrexate treatment; the obstetrician did
not discuss the effect of methotrexate on a viable pregnancy
because she did not consider this to be the case.
The woman was admitted to a public hospital later that day.
Further blood tests were taken, methotrexate was administered, and
she was discharged home; follow-up blood tests were arranged. The
first of these showed a further marked rise in hormone levels
indicating a continuing pregnancy; two days later she had abdominal
pain, backache and nausea and returned to the hospital, where a
second ultrasound scan revealed a single live fetus, though smaller
than expected, in the uterus. Because there was a significant risk
of fetal malformation in this unusual situation, the pregnancy was
terminated. The couple made a complaint that the diagnosis of
ectopic pregnancy and advice to terminate was incorrect, and that
the woman was not given sufficient time to reflect on her decision
to take the methotrexate option, or sufficient information about
the risks posed to a potentially viable fetus.
It was held that the obstetrician breached Right 4(1) in relying
too heavily on the ultrasound findings in reaching her diagnosis,
and deviating from standard practice in not arranging repeat checks
before administering methotrexate.
She further breached Right 6(1) by not providing sufficient
information about the limitations of the diagnosis on a single
ultrasound scan. Having, albeit incorrectly, diagnosed ectopic
pregnancy, her discussion of the available options and potential
risks was satisfactory, although it was recommended that she needed
to give the couple sufficient time to reflect on the decision. The
public hospital was held to have acted in accordance with the
protocol in place at the time, and was appropriately guided by the
obstetrician's diagnosis and decision to administer
methotrexate.
Following the event, both the obstetrician and the hospital
apologised to the couple for the incorrect diagnosis, and reviewed
their practices accordingly. Updated polices were put in place at
the hospital to minimise the risk of a similar occurrence in the
future, and to provide appropriate pregnancy loss counselling. The
fertility clinic also improved its procedures in relation to early
pregnancy care.
Page Section: Right Content Column
Top of Page